These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2136147)

  • 1. Antifibrinolytic therapy and cerebral vasospasm.
    Haley EC; Torner JC; Kassell NF
    Neurosurg Clin N Am; 1990 Apr; 1(2):349-56. PubMed ID: 2136147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
    Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage.
    Kassell NF; Haley EC; Torner JC
    Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral vasospasm.
    Weir B; MacDonald L
    Clin Neurosurg; 1993; 40():40-55. PubMed ID: 8111992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of subarachnoid hemorrhage.
    Brisman MH; Bederson JB
    New Horiz; 1997 Nov; 5(4):376-86. PubMed ID: 9433990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of ticlopidine and nicardipine on the prevention of symptomatic vasospasm after aneurysmal rupture].
    Fujita K; Yamashita H; Masumura M; Ehara K; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988 May; 16(6):741-6. PubMed ID: 3412560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective trial of treating aneurysmal meningeal hemorrhage by delayed operation under cover of antifibrinolytic therapy].
    Irthum B; Chazal J; Commun C; Chabannes J; Janny P
    Neurochirurgie; 1986; 32(2):122-8. PubMed ID: 3523271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of aneurysmal subarachnoid hemorrhage.
    Miller J; Diringer M
    Neurol Clin; 1995 Aug; 13(3):451-78. PubMed ID: 7476815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988; 16(5 Suppl):509-15. PubMed ID: 3399005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in arterial ketone body ratio (AKBR) in subarachnoid hemorrhage patients].
    Tamaki T; Isayama K; Teramoto A
    No To Shinkei; 1996 Feb; 48(2):161-7. PubMed ID: 8865696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
    Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
    No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Posterior cerebral aneurysm associated with complete occlusion of the middle cerebral artery caused subarachnoid hemorrhage: a case report].
    Kawamura A; Yamada H; Nagao T; Tamaki N
    No Shinkei Geka; 1996 Dec; 24(12):1107-11. PubMed ID: 8974093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage.
    Beck DW; Adams HP; Flamm ES; Godersky JC; Loftus CM
    Stroke; 1988 Jan; 19(1):63-7. PubMed ID: 3336904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.
    Chwajol M; Starke RM; Kim GH; Mayer SA; Connolly ES
    Neurocrit Care; 2008; 8(3):418-26. PubMed ID: 18386187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of subarachnoid hemorrhage.
    Quandt CM; de los Reyes RA; Diaz FG; Ausman JI
    Drug Intell Clin Pharm; 1982 Dec; 16(12):909-15. PubMed ID: 6129959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cerebral aneurysms: further facts and additional myths.
    Ausman JI; Diaz FG; Malik GM; Andrews BT; McCormick PW; Balakrishnan G
    Surg Neurol; 1989 Jul; 32(1):21-35. PubMed ID: 2660308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.